#DYK #Anelloviruses demonstrate immune favorability? This unique privilege to evade the immune system enables our vectors made from anelloviruses to deliver #GeneticMedicine without causing a robust immune response. Discover more here: brnw.ch/21wJCqB #AnelloInsights

Stemming from our new data at #ASGCT2024, Tuyen Ong, CEO, was featured in a FierceBiotech article spotlighting our Anellovector, a new class of viral vector, and it’s promise of redosability compared to traditional AAVs. Read about it here: fiercebiotech.com/research/asgct…

It was exciting to present at #ASGCT2024 alongside these other #FlagshipFounded companies! Check out the full summary and highlights to learn more about the redosability of our novel Anellovector, a new class of viral vector.

#ICYMI we presented new preclinical data on our Anellovectors at #ASGCT2024! It was an exciting opportunity to be on the ground with other #biotech experts & share our unique approach to transforming #GeneticMedicine. Dive deeper into our presentations: ringtx.com/science/public…

#DYK most people already have antibodies to AAVs, limiting accessibility of current gene therapies? Unlike AAVs, Anelloviruses don’t elicit a robust immune response, enabling Anellovectors to deliver #GeneticMedicine to almost anyone. Learn more: bit.ly/3XwjmkQ

Exciting news from Flagship Pioneering as they announce the raise of $3.6 billion to fuel breakthrough innovations to transform human health and sustainability. We are proud to be #FlagshipFounded and part of an ecosystem of companies taking bold scientific leaps for a better future

Earlier this month, we closed our offices for a #SummerShutdown to allow our team to rest, rejuvenate, & participate in summer activities that matter to them! We prioritize a work-life-balance so our team can continue their hard work toward revolutionizing programmable medicines.

🏓 Last month, our team swapped lab coats for paddles and had a blast on the #Pickleball court for our summer outing. It was an evening full of games, laughs, and celebrations in honor of our 7th anniversary! Check out these photos from the event!

🧬🔬 Happy #NationalInternDay! Our co-ops are helping us push the boundaries of what is possible and we’re so thankful for their hard work and dedication to the team. The future of #biotech is bright, and we can’t wait to see where these #FutureLeaders end up.

Check out the latest episode of CGTLive® where our Chief Medical Officer and Head of Translational Research, Chris Wright, MD, PhD, discussed our latest data findings on anelloviruses and the promise they hold to revolutionize #GeneTherapy. Watch here: bit.ly/3A48ZLs

Thrilled to share our recent publication in Nature Communications on the unique structure of anelloviruses, the foundation of our Anellogy™ platform. Learn how their structure enables immune evasion and how anelloviruses are transforming #GeneticMedicine: go.nature.com/3Xee6Sk

#DYK our Anellovectors can be engineered to have an expanded payload capacity beyond natural anellovirus genome sizes? Data presented at #ASGCT2024 unveiled the broadened therapeutic potential of this novel class of viral vectors across diseases. More: bit.ly/47wjJio

At Ring, our values drive our team of pioneers forward. Together as #OneRing, we are dedicated to fostering an audacious, inclusive, and resilient culture as we work to build a better future for patients.

Our CTO, Konstantin Konstantinov, will be delivering the opening keynote lecture at the upcoming SPICA conference, discussing the latest breakthroughs across the Preparative and Industrial Chromatography field aiming to advance #GeneticMedicine. More: bit.ly/3Y0mow6

We're attending #ESGCT2024 where we're showcasing successful genomic payload expansion of our novel AnelloVector, further validating it as the first gene delivery vector system based on the human commensal anellovirus. Learn more here: bit.ly/4dUP6EQ

Excited to announce our new strategic partnership with A*STAR and the snec_seri to advance innovative R&D efforts and support the continued development of the biomedical science ecosystem in the region. To learn more about the news, read here: ringtx.com/news/ring-ther…

Our exciting partnership announcement was just featured in FierceBiotech, highlighting our continued efforts in supporting the flourishing biotech ecosystem in the Singapore region and the advancement of our novel Anellogy™ platform. Read here: fiercebiotech.com/research/ring-…

#ICYMI our CTO Konstantin Konstantinov, Ph.D., recently spoke with Life Science Connect, highlighting our novel AnelloBricks platform as a potentially transformative solution for the #GeneticMedicines space. Learn more here: bioprocessonline.com/doc/how-ring-s…

Mark your calendars - we'll be at #ASGCT2025! Come say hello and check out our presentations highlighting new data from our #Anellogy platform. See you in New Orleans!

New data at #ASGCT2025 on our AnelloBricks® platform! This in vitro approach to producing functional anellovirus vectors has the potential to offer many advantages in manufacturing compared to existing vector systems. Read more and attend our talk: bit.ly/4mdbqPd